Medical - Instruments
Industry Rank
More Info
The Zacks Industry Rank assigns a rating to each of the 254 X (Expanded) Industries based on their average Zacks Rank.
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.
The industry with the best average Zacks Rank would be considered the top industry (1 out of 254), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (254 out of 254) would place in the bottom 1%.
Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank
The Zacks Industry Rank assigns a rating to each of the 254 X (Expanded) Industries based on their average Zacks Rank.
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.
The industry with the best average Zacks Rank would be considered the top industry (1 out of 254), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (254 out of 254) would place in the bottom 1%.
Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank
+0.01%
YTD Return More Info
Year to Date (YTD) Return shows the median percentage price change for the respective equally-weighted Industry since the beginning of the year.
Updated Apr 16
Sector: Medical
Performance
| Total Return % | IVV(iShares-SP500) | |
|---|---|---|
| 1 Month | 2.62 | 5.72 |
| 3 Months | -2.29 | 11.43 |
| YTD | 0.01 | NA |
| 1 Year | 33.21 | 51.61 |
| 3 Years | 42.46 | 62.57 |
| 5 Years | 98.91 | 114.07 |
Medical - Instruments Performance
Key Metrics for
Industry Earnings
| Industry | IVV(iShares-SP500) | |
|---|---|---|
| PE (F1) | 43.50 | 22.39 |
| PEG (Ratio) | 3.21 | 2.40 |
| Proj EPS Growth | 27.66% | 13.37% |
| Hist EPS Growth | 8.72% | 9.34% |
| Net Margin | -23.05% | 10.59% |
| Hist Sales Growth | 9.25% | 5.37% |
| Hist Dividend Growth | 0.00% | 0.00% |
Financial Ratios
| Industry | IVV(iShares-SP500) | |
|---|---|---|
| Beta | 1.15 | 1.08 |
| ROE | -22.11 | 14.98 |
| ROA | -16.72 | 5.72 |
| ROI | -18.33 | 8.98 |
| Debt-to-Equity | 0.06 | 0.66 |
| Current Ratio | 3.31 | 1.39 |
| Cash Flow ($/share) | -0.52 | 1,778.00 |
| Price to Book | 5.56 | 0.00 |
| Price To Sales | 6.92 | 3.46 |
| Dividend Yield | 0.00% | 1.28% |